AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Choosing between small-cap index funds and total market exposure affects risk and return in retirement. This comparison highlights key differences and decisions.
28,577 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Investors are watching the CLARITY Act as the Senate considers the bill this week. Traders say crypto markets massive...
SpaceX kicked off a $25 billion bond offering just weeks after a historic $75 billion IPO, while its stock trades wel...
Ethereum-focused ETFs faced a heavy outflow spell, totaling $708 million over 14 sessions, while XRP and Solana poste...
CAVA Group's shares jumped on expansion progress, signaling investor enthusiasm for growth. This article breaks down ...
RAD Intel debuts a Regulation A+ offering at $0.91 per share, pitching an AI-driven marketing engine as the next oppo...
A forecast from Microsoft-backed Copilot AI points XRP toward a potential tripling in price by mid-2026, driven by in...
Bitcoin extended a retreat as investors moved cash from crypto into equities ahead of SpaceX's anticipated mega IPO. ...
A hypothetical SpaceX IPO could ride a powerful tailwind if a Google cloud deal brings $30 billion in AI compute reve...
Long-term holders in NVDA, AMD, and LLY are posting outsized gains as AI and GLP-1 drug momentum persists. Traders wh...
Institutional players are accelerating tokenization and on-chain strategies, even as many traditional investors lag b...
Adobe stock dropped after earnings despite solid results, leaving many investors puzzled. This article unpacks the fo...